Patrick Raber, PhD
Dr. Patrick Raber is a scientific liaison with Adaptive Biotechnologies, a biotechnology company based in Seattle, Washington that specializes in combining high-
PUBLICATIONS ON ADAPTIVE BIOTECHNOLOGIES IMMUNOSEQ
DeWitt WS, et al. A Public Database of Memory and Naive B-Cell Receptor Sequences. PLoS One 2016. PMID:27513338
Howie B, et al. High-throughput pairing of T-cell receptor alpha and beta sequences. Sci Transl Med 2016. PMID:26290413
Tweets by Adaptive Biotechnologies
The technology to measure T cells with precision and at scale exists. A more complete understanding of the immune response to SARS-CoV-2 including both T cells and antibodies could offer insights to inform public health interventions. scientificamerican.com/article/what-d…
Join us at @DDWMeeting May 21-24 to hear from researchers utilizing immunoSEQ® to observe the humoral and cellular response to SARS-CoV-2 mRNA vaccination in patients with IBD. More info: adaptivebio.tech/7a9 For Research Use Only. Not for use in diagnostic procedures.
.@MatthieuAllez will present data at @DDWMeeting demonstrating immunoSEQ® identified T-cell receptors linked to Crohn’s Disease from blood samples. Saturday, May 21st from 10:00am-10:15am PDT. adaptivebio.tech/7a9 For Research Use Only. Not for use in diagnostic procedures.
What’s it like to be an intern at Adaptive? Sydney reflects on her experience and shares advice to all 2022 Adaptive interns. adaptivebio.tech/jom
Meet Vita! Originally from Ukraine, she’s an Executive Assistant to the President and Manager of our NYC Office. Fun facts: she’s bilingual and when she isn’t working, she unwinds by reading and going on walks with her dog. #HumansOfAdaptive
New publication @JCI_Insight: Data confirms T cells play a central role in mounting an immune response against SARS-CoV-2 that can persist for at least 15 months. adaptivebio.tech/5e7
MRD Chief Commercial Officer Nitin Sood discusses being on the patient’s side of the cancer journey and the profound influence it has in shaping his career path. adaptivebio.tech/k9a
Thank you to each member of our Seattle and South San Francisco lab and lab support teams. This is a time to celebrate the important and essential work you do and express our collective appreciation. #LaboratoryProfessionalsWeek #LabWeek2022
Explore the principles of our immune medicine platform and its potential application to the field of adoptive cell therapy in our upcoming webinar. adaptivebio.tech/7zi For Research Use Only. Not for use in diagnostic procedures.
It’s Medical Laboratory Professionals Appreciation Week! Our laboratory operations team is the heartbeat of Adaptive. Today and every day, we thank you for your ongoing dedication and persistence to improve the lives of patients. #LabWeek2022
Chief Operating Officer Mark Adams will share an overview of Adaptive’s Diagnostics business at this year’s Life Science Innovation Northwest 2022 conference. Join him on Wednesday, April 20th at 10am-12pm PT. Full agenda and registration here: adaptivebio.tech/hx3
Join Patrick Raber at World Vaccine Congress (@vaccinenation) where he will be discussing T-cell immune response, themes in vaccine development, and COVID-19 variants. Wednesday, April 20th at 3:40pm ET. Click here for the full agenda: adaptivebio.tech/1uw
Join @sbenzeno, @SetteLab, @vaccinesguy07, @levy_o and Rafick-Pierre Sékaly for a @vaccinenation panel discussion on Immune Profiling: Lessons learned from the coronavirus pandemic to help inform future vaccine development. 4/20 at 9:10am ET. Agenda: adaptivebio.tech/1uw
Adaptive is hosting a symposium at #AACR22 with presentations on how the immunoSEQ Technology is uniquely suited to help answer questions related to immuno-oncology. Visit us at Booth 2210. adaptivebio.tech/6uy For Research Use Only. Not for use in diagnostic procedures.
Leadership. Mentorship. Growth. To power the age of immune medicine, we empower each other. Adapters share why mentorship is more important than ever. #WomensHistoryMonth
We recently spoke with Women in Immune Science (WISE) award winner, Ana Bolivar (@AnaMBolivarA), a PhD candidate in Dr. Vilar’s lab at the University of Texas @MDAndersonNews. Ana shared her research and hope for the future with us. Read the interview: adaptivebio.tech/0kw
More extensive deployment of existing methods for measuring T-cell immunity to SARS-CoV-2 could provide a more complete profile of the immune status for at risk populations and offer insights for informing public health interventions. Read @SciImmunology: adaptivebio.tech/zye
Don’t miss leaders from @FoundationATCG, @YaleGICancers, and @AdaptiveBiotech for a @MAPSmedaffairs workshop about increasing gender equity in advisory boards. This session will define observed gaps in gender equity and share practical tips. Learn more: adaptivebio.tech/ckl
Looking forward to my presentation at #IO360NYC! I’ll be sharing an overview of the @AdaptiveBiotech immune medicine platform and how it can help inform immune-based therapies. Hope to see you there! Full agenda at adaptivebio.tech/bzt. @conferenceforum #IO #ImmunoOncology Retweeted by Adaptive Biotech